Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **p75 neurotrophin receptor (p75NTR) and sortilin complex** is a heteromeric receptor assembly crucial for proneurotrophin-mediated signaling in the nervous system[1][3][5]. p75NTR is a type I transmembrane receptor belonging to the tumor necrosis factor receptor superfamily; sortilin is a member of the Vps10p domain receptor family which functions as a sorting receptor and coreceptor[2][4]. When immature proneurotrophins (such as proNGF, proBDNF, or proNT-3) are present, their pro-domain binds to sortilin, while the mature domain binds to p75NTR, forming a ternary signaling complex. This complex is distinct in its ability to transduce cell death (apoptosis) signals, contrasting with the survival-promoting effects seen when mature neurotrophins bind to p75NTR and Trk co-receptors[1][5]. The complex plays key roles in neuronal development, synaptic modulation, injury response, and immune signaling, but is also implicated in pathological processes such as neurodegeneration and tumor biology. Targeting this complex poses both promise and risk as a therapeutic strategy due to its dual roles in neuronal survival and apoptosis[5].
Modulation of neurotrophin binding (pro-neurotrophin binds sortilin, mature neurotrophin binds p75NTR); Promotion of apoptosis via proneurotrophin-induced activation; Regulation of intramembrane proteolysis and receptor shedding (leading to downstream signaling); Competitive inhibition of ligand binding (for potential inhibitors).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p75 neurotrophin receptor and sortilin complex (p75NTR/sortilin complex).